Updated 02:01 GMT, 16 Nov 2026 SPX 7,561.67 -0.40% NDX 27,943.74 -1.22% VIX 19.30 +3.21% GOLD 3,876.40 -0.25% CL 88.33 -0.26% BTC 64,613.34 +0.76%
NAS100 27,944 −1.22% S&P 7,562 −0.40% GOLD $3,876 −0.25% BTC $64,613 +0.76% VIX 19.30 +3.21% latest tape · as of 02:01 UTC
The Screen · Energy · Oil & Gas Midstream

Pembina Pipeline Corp logoPembina Pipeline Corp

PBA · the NYSE · USD · Market cap $28.1B · 2,974 employees

Pembina Pipeline Corporation provides energy transportation and midstream services.

FAIL · Does not pass the screen
50.31 USD

Price as of 13 Nov 2026Daily close, not a live quote

Screened 2026-11-13 · the tape above runs as of 02:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price50.31 USD at the 13 Nov 2026 close
  • Fair value33.02. Our model only; only one analyst covers it, too few to cross-check it.
  • Our value readOvervalued vs our fair value, as of 13 Nov 2026
  • Our regime readMarkup, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • OptionsOpen interest leans heavily to calls (put/call 0.13)
  • Last reviewed13 Nov 2026 (3 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $33.02 to $37.97, base estimate $33.02 (screen dated 2026-11-13).

Current read
Markup ?
Overvalued · screened 2026-11-13
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 0.13, read 2026-11-14
  • Ethical does not pass the values gate
Price50.31 USD
Fair value33.02Our model only; only one analyst covers it, too few to cross-check it.
Ethical score70.0/100
Value readOvervaluedas of 13 Nov 2026
Our investment reviews on this name
2026-10-18Read Markup48.52+3.7% to today ✓Distribution gives way to Markup first Markup read since August
2026-10-11Read Distribution47.15+6.7% to today Markdown gives way to Distribution
2026-10-02Read Markdown46.39+8.5% to today Accumulation gives way to Markdown with volume flow in agreement
2026-09-09Read Accumulation48.59+3.5% to today ✓Markup gives way to Accumulation

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

Pembina Pipeline Corp holds its Markup at $50.31. Consolidating, no directional conviction, held for 11 days.

As held on the ledger · 2026-11-13
PhaseMarkup
Quantitative stateConsolidating, no directional conviction, held for 11 days
Price at the screen$50.31
Valuation23.56 trailing · 21.58 forward price to earnings
Values screenFAIL · score 70.0
The Workings

Five Screens, Shown in Full

Does not pass. Debt ratio

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 37.43% Below 33% Interest-bearing debt is 37.4% of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash 0.00% Below 33% Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
Receivables 2.23% Below 49% Money owed to the company is 2.2% of assets, under the 49% limit. Pass
Revenue purity 0.14% Below 5% Only 0.1% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Pembina Pipeline's business is in a permissible area, but its interest-bearing debt is about 37% of the company, just over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-11-14. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when PBA's ethical verdict changes

Today PBA does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our model only; only one analyst covers it, too few to cross-check it.

Our analysis reads Overvalued vs our fair value, as of 13 Nov 2026: it trades above our $33.02 fair value estimate, narrow competitive moat, 21.70% revenue growth.

How a fair value is estimated: discounted cash flow (DCF).

33.02Conservative33.02Base case37.97Growth case 50.31Price

Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. The price runs 52.4% above the base estimate.

Reading the gap · Both our model and the Street see limited upside at this price.

Price History & Projections

Where our models see it going: fair-value estimate $33.02, with a range of $33.02 to $37.97, dated to the 2026-11-13 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Oil Pipelines Priced for Better Days

Think of midstream pipelines as the quiet plumbing that moves Canadian oil through snow and regulatory fights. Pembina keeps those pipes running, yet the business just posted falling revenue and sits on a narrow moat that offers little protection when volumes swing.

We pass. The shares trade at more than twenty-three times forward earnings while our fair value sits roughly forty percent lower. In a cyclical sector that number is not a bargain, it is a warning that current margins may already reflect peak conditions.

The real risk is simple: energy volumes and pricing can turn quickly, and a narrow moat gives little cushion when they do. Ethical checks clear, but the valuation gap does not. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E21.6xfairly priced for its growth rate
Trailing P/E23.6xa premium valuation
EPS, trailing2.05
EPS, forward2.24
Revenue growth+21.7%strong top-line growth
Profit margin24.8%healthy profit margins
Return on equity12.1%a solid return on shareholder capital
FCF yield6.08%
Dividend yield4.47%
Debt to equity0.80moderate, manageable leverage
Current ratio0.75below 1: short-term bills exceed liquid assets
52-week range36.20 - 51.58
MoatNARROW
Market cap$28.1B
Employees2,974

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: its business and earnings are exposed to Canada and to currency swings.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

PBA trades on the NYSE (the company is based in Canada). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-15 Markup $50.31 +4.2% Entry 12

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 4.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 35%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (1 analysts) rates it buy, with a mean price target of $41.

2026-11-08 Markup $48.29 -6.0% Entry 11

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 6.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 35%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (1 analysts) rates it buy, with a mean price target of $41.

2026-11-01 Markup $51.36 +5.9% Entry 10

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 5.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 35%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (1 analysts) rates it buy, with a mean price target of $41.

2026-10-25 Markup $48.52 +0.0% Entry 9

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 35%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (1 analysts) rates it buy, with a mean price target of $41.

2026-10-18 Markup · changed $48.52 +2.9% Entry 8

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 20% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 35%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (1 analysts) rates it buy, with a mean price target of $41.

2026-10-11 Distribution · changed $47.15 +1.6% Entry 7

The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 1.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 20% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 35%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (1 analysts) rates it buy, with a mean price target of $41.

2026-10-02 Markdown · changed $46.39 -4.5% Entry 6

The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 4.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 20% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 35%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (1 analysts) rates it buy, with a mean price target of $41.

2026-09-09 Accumulation · changed $48.59 -2.6% Entry 5

The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 2.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 20% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 35%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (1 analysts) rates it buy, with a mean price target of $41.

2026-08-08 Markup $49.91 +3.2% Entry 4

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 3.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 20% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 35%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (1 analysts) rates it buy, with a mean price target of $41.

2026-07-18 Markup $48.35 +0.0% Entry 3

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 20% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 35%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (1 analysts) rates it buy, with a mean price target of $41.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on PBA

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in PBA's Space

Screened names in the same industry · explore each on its own page.

The Political Ledger · Congressional Disclosures
Disclosures naming PBA
DatePoliticianPartyTypeAmount
2026-08-27 Kevin Hern Republican sell 15K–50K
2026-08-27 Kevin Hern Republican sell 15K–50K
2026-08-27 Kevin Hern Republican sell 15K–50K
2026-05-15 Ro Khanna Democrat buy 1K–15K
2026-05-01 Ro Khanna Democrat buy 15K–50K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $46.30 +6.0% · $1,060 +6.0%
2 months $44.34 +10.7% · $1,107 +10.7%
3 months $43.96 +11.6% $0.52 $1,128 +12.8%
6 months $38.71 +26.8% $0.52 $1,281 +28.1%
1 year $36.46 +34.6% $1.04 $1,374 +37.4%
2 years $34.53 +42.1% $3.02 $1,508 +50.8%
3 years $27.64 +77.5% $5.00 $1,956 +95.6%
5 years $25.83 +89.9% $8.61 $2,232 +123.2%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever PBA does next, these words stay.

Pembina Pipeline Corp · PBA · Markup · $50.31
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.